Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 7

Abstract

Introduction: Basal insulin is among the second line treatment options for Type 2 Diabetes Mellitus (T2DM). Efficacy and safety of basal insulin in patients of T2DM, uncontrolled with Oral Antidiabetic Agents (OAAs) remains understudied in the Indian setting. Aim: To assess the efficacy and safety of insulin glargine in patients with T2DM who have uncontrolled glycaemic levels despite single or two OAAs therapy. Materials and Methods: In this prospective, open label study, T2DM patients above 40 years of age, having inadequate glycaemic control [Glycosylated Haemoglobin (HbA1c) above 8% and/or fasting glucose level of 140 mg/dl and above] with single or two OAAs over three consecutive months were included. Dosing of insulin glargine was adjusted as per Fasting Blood Glucose (FBG) and Post Prandial Blood Glucose (PPBG) levels. Patients were followed for 12 weeks and data was analysed by comparing 12th week findings to baseline values. Results: In 40 cases included in final analysis, mean age was 56.35 ± 6.77 years, 52.5% were females and mean body mass index was 26.96 ± 4.59 kg/m2 . Compared to baseline, significant reduction in HbA1c, FBG and PPBG blood glucose (all p<0.05) was seen. HbA1c goal of < 7% was achieved in 37.5% cases. Systolic (p>0.05) and diastolic (p<0.05) blood pressures reduced at 12 weeks as compared to baseline. Increase in weight was modest with mean increase of 1.06 kg (p>0.05). Overall, 14 symptomatic hypoglycaemia events were observed with none being severe. Conclusion: Short term administration of insulin glargine is effective in reducing glycaemia and is safe with lower rates of severe hypoglycaemia. It can be considered in patients with uncontrolled T2DM on mono- or two- OAAs treatment.

Authors and Affiliations

Ajay Aggarwal, Roopak Wadhwa

Keywords

Related Articles

The Impact of Three-month Training Programme on Foot Care and Self-efficacy of Patients with Diabetic Foot Ulcers

Introduction: Patient’s self-efficacy in disease management and foot care is considered as an important indicator in controlling the complications of diabetes. Aim: This study was aimed to determine the effect of threemo...

N-Terminal-pro Brain Natriuretic Peptide in Assessing the Severity of Stable Coronary Artery Disease

ABSTRACT Introduction: Coronary Artery Disease (CAD) occurs due to atherosclerosis which results in progressive narrowing of coronary artery lumen. N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) has been used as a...

Assessment of Mental Disability using Indian Disability Evaluation Assessment Scale in Obsessive Compulsive Disorder and Dysthymic Disorder

ABSTRACT Introduction: Obsessive Compulsive Disorder (OCD) is characterised by recurrent obsessions or compulsions that are severe enough to be time-consuming or cause marked distress or significant impairment and is gi...

Parietal Wall Abscess Perforating to Transverse Colon: A Rare Presentation

Extrapulmonary tuberculosis affects an isolated organ or presents secondary to pulmonary involvement. Lymph nodes are the common sites for extrapulmonary tuberculosis. Primary extrapulmonary tuberculosis involving pariet...

Download PDF file
  • EP ID EP355570
  • DOI 10.7860/JCDR/2017/27649.10214
  • Views 74
  • Downloads 0

How To Cite

Ajay Aggarwal, Roopak Wadhwa (2017). Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study. Journal of Clinical and Diagnostic Research, 11(7), 21-24. https://europub.co.uk./articles/-A-355570